Probiotics for Bloating Ireland: What the Evidence Says
Probiotics for Bloating Ireland:
What the Evidence Actually Says
Bloating is one of the most common gut complaints in Ireland. This guide covers how probiotics interact with gut microbiome imbalance, what the clinical trials actually show, and how to read a probiotic label before you buy.
Why the Gut Microbiome Is Central to Bloating
Bloating is not only a dietary problem. For a proportion of people with chronic or recurrent bloating, particularly those with IBS or unexplained gut symptoms, the gut microbiome appears to play a role in both the cause and the response to treatment.
A 2025 study published in In Vivo examined gut microbiota composition in adults diagnosed with functional abdominal bloating. 90.5% of patients showed a dysbiosis index of 15 or higher, indicating significant microbial imbalance. Over 80% had markedly reduced levels of beneficial bacteria, including Bifidobacterium species and Faecalibacterium prausnitzii. Elevated levels of Proteobacteria were found across the group.[1]
A 2024 review in Microorganisms (Carabotti et al.) reported that gut microbiota imbalances are associated with functional abdominal bloating and distension, and described restoring microbial balance as a promising direction for longer-term management.[2]
The mechanism is not only about gas volume. Microbiome composition is associated with intestinal motility, epithelial barrier integrity, visceral sensitivity and immune signalling. This is one reason short-term symptom-relief products offer immediate comfort without changing the underlying picture for people with chronic symptoms.
What Actually Causes Bloating, and When Probiotics May Help
Before reaching for any supplement, it helps to understand which type of bloating you are dealing with. The published evidence is relevant to some causes and not to others.
Imbalance between bacterial populations, associated with gas production and motility disruption. This is the context in which probiotics have been most studied.
Antibiotics reduce microbial diversity, often with temporary bloating and gas. Probiotics have been studied in this context, with mixed results by strain.
Lactose or fructose malabsorption causes bloating through a different mechanism. Dietary assessment is the primary route here, not supplementation.
Visceral hypersensitivity and altered motility are associated with bloating in IBS. Most of the published probiotic trials were conducted in this population.
Small intestinal bacterial overgrowth requires medical diagnosis and specific management. This is a clinical matter, not a supplement one.
Psychological stress is associated with altered gut motility and microbiome composition. Evidence for supplement effects here is preliminary.
Persistent bloating accompanied by unexplained weight loss, blood in stools, severe abdominal pain, or symptoms that progressively worsen should be investigated by a GP or gastroenterologist before starting any supplement. These can be signs of conditions requiring medical diagnosis and treatment. The HSE is the appropriate reference for health information in Ireland.
What the Clinical Trials Actually Show
The honest summary: the evidence is positive but nuanced, and the certainty grading in the largest review is low. Multi-strain formulations show more consistent signals than single-strain products. Here is what the key publications report.
A 2024 narrative review in Microorganisms reported that a meta-analysis of 17 randomised controlled trials found a significant effect of probiotics on bloating scores overall. An international guideline process using systematic review and consensus voting recorded 70% agreement and a moderate grade of evidence for an effect of certain probiotics on bloating in people with IBS.
Key caveat: the effect was associated with specific probiotic strains, not with probiotics as a category. Strain selection matters.[2]
In a randomised controlled trial at Mayo Clinic, patients with diarrhoea-predominant IBS received the De Simone Formulation or placebo over 8 weeks. Abdominal bloating was significantly reduced in the probiotic group (p = 0.046), with no significant between-group difference in other symptoms measured.
Reference: Kim HJ, Camilleri M, McKinzie S, et al. Aliment Pharmacol Ther. 2003;17(7):895-904. PMID 12656692. Check the paper for the exact dosing used.[3]
A second RCT by Kim et al. in IBS patients with bloating as the primary complaint reported a statistically significant reduction in flatulence over the treatment period (placebo 39.5 ± 2.6 versus probiotic 29.7 ± 2.6, p = 0.011).
Reference: Kim HJ, Vazquez Roque MI, Camilleri M, et al. Neurogastroenterol Motil. 2005;17(5):687-696. PMID 15836468.[4]
This 2023 systematic review and meta-analysis in Gastroenterology found that combination probiotics showed a benefit over placebo for abdominal bloating or distension (RR of persistence 0.75; 95% CI 0.64 to 0.88), though certainty of evidence was graded very low because of substantial heterogeneity between studies.
The takeaway: the signal favours multi-strain combination products. Single-strain Lactobacillus and Saccharomyces products did not show a significant benefit for bloating in this review.[5]
The European Society for Primary Care Gastroenterology guide, based on systematic review of placebo-controlled RCTs, recorded 70% agreement at a moderate evidence grade that specific probiotics reduce bloating and distension and improve bowel movement frequency in some IBS patients. The guide emphasises strain specificity: results cannot be generalised between different preparations.[6]
Most of the trials above were conducted in people with diagnosed IBS or functional bowel disorder, not in the general population with occasional bloating. The largest review graded certainty as very low. No trial has been conducted on CDS22-formula under that product name, and clinical evidence attaches to the formulation and dose used in a trial rather than to a retail product.
No authorised EU or Irish health claim exists for probiotics and bloating. Nothing in this section should be read as evidence that any product on sale treats a condition.
Probiotic Strains Researched for Bloating: What the Evidence Says
Not all probiotics are equivalent. Formulation identity, meaning the specific strain deposit codes, determines which published evidence applies to a given product. The table below summarises strains and combinations with published evidence in bloating and IBS.
| Probiotic / Strain | Bloating Evidence | Trial Type | Notes |
|---|---|---|---|
| De Simone Formulation (8 strains, NCIMB 30435 to 30442) | Positive signal | Two RCTs, plus meta-analysis coverage | Bloating reduced (p=0.046) in an IBS-D RCT; flatulence reduced (p=0.011) in an IBS-with-bloating RCT. Supplied in Ireland as CDS22-formula. |
| Lactobacillus plantarum 299v | Mixed | Several RCTs in IBS-D | Some benefit for overall IBS symptoms; low certainty for bloating specifically per Goodoory 2023. |
| Bifidobacterium longum 35624 | Moderate | RCT in IBS | Reduced bloating and abdominal discomfort in IBS in a published RCT. Single-strain product. |
| L. acidophilus NCFM + B. lactis Bi-07 | Positive | Double-blind RCT in functional bowel disorder | Bloating improved versus placebo at 4 weeks (PMC4372813). |
| Low-dose single-strain products (under 10bn CFU) | No consistent evidence | Not well studied at low dose | Limited published evidence for bloating specifically at these doses. |
| Saccharomyces boulardii | No benefit for bloating | 5 RCTs in IBS meta-analysis | No significant benefit for bloating per Goodoory 2023. Separate evidence base for antibiotic-associated diarrhoea. |
Graded from published RCTs and systematic reviews. Probiotics are food supplements. This table is for educational reference only, is not a comparison of retail products, and does not constitute medical advice.
How to Read a Probiotic Label in Ireland
Browsing for a probiotic in Ireland can be overwhelming, and packaging claims are tightly restricted by law, so the label tells you less than you might expect. Here is what is actually worth checking.
| Factor | What to Look For | Why It Matters |
|---|---|---|
| Strain identification | Named strains with published deposit codes, for example NCIMB codes | Lets you check which published trials relate to that exact strain. Generic species names without codes cannot be cross-referenced to research. |
| CFU count | A stated CFU figure, and a stated point at which it applies | CFU is one factor among several. A higher number is not automatically better. What matters is whether the formulation and dose match one that has been studied. |
| Multi-strain versus single-strain | Multi-strain formulations | Goodoory et al. (2023) found a signal for combination probiotics for bloating that was not present for single-strain Lactobacillus or Saccharomyces products. |
| Storage requirements | Clear storage instructions, and a supplier who follows them | Live bacteria are heat-sensitive. Storage and handling affect how many viable organisms remain by the time you take the product. |
| Time commitment | 4 to 8 weeks minimum | Most trials showing a benefit ran for 4 to 8 weeks. Short-term use is unlikely to produce measurable change. |
| Published evidence on the formulation | Named trials on the specific strain set, not on the species names alone | Evidence attaches to the formulation studied. A product sharing a species name with a trialled product is not the same thing. |
In Ireland, probiotic food supplements are regulated by the FSAI (Food Safety Authority of Ireland), with medicines regulated separately by the HPRA. Under EU Regulation 1924/2006, no health claim may be made for a probiotic unless it has been specifically authorised. There is currently no authorised claim linking probiotics to bloating. This is why packaging claims are limited, and why published clinical evidence, read directly, is a better guide than product marketing. VAT on food supplements in Ireland is 13.5%.
What to Expect: A Realistic Timeline
One common reason people abandon probiotic supplementation is expecting too much too quickly. Based on the durations used in published trials, here is a realistic guide.
1–2
Introducing large numbers of live bacteria can temporarily increase gas and bloating. This is commonly reported and usually short-lived. If symptoms are severe or persist beyond 2 weeks, consult a healthcare professional.
2–4
Changes in gut microbiota composition have been measured within 2 weeks of consistent use in some studies. Whether that corresponds to a change in symptoms varies considerably between individuals.
4–8
The majority of RCTs reporting a significant effect on bloating used 4 to 8 weeks of supplementation. This is the period over which the published trials measured their outcomes.
8+
Gut microbiota composition tends to revert following discontinuation. Trials generally did not follow participants long term, so the evidence for sustained use beyond the trial window is limited.
CDS22-formula in Ireland
CDS22-formula is the original 8-strain De Simone Formulation, developed by Professor Claudio De Simone and manufactured by EOS2021 S.r.l. It is the formulation used in the Kim et al. trials cited in this guide. Each sachet provides 450 billion CFU across eight strains, each identified on the current Irish label by its NCIMB deposit code.
| Specification | CDS22-formula |
|---|---|
| Live cultures per sachet | 450 billion CFU |
| Strains | 8, identified by NCIMB deposit codes (NCIMB 30435 to 30442) |
| Formats | 450bn sachets, 112bn vegetable capsules, infant drops |
| Manufacturer | EOS2021 S.r.l. |
| Storage | Refrigerated +2°C to +8°C; shelf-stable to 25°C for up to 7 days per the manufacturer's storage leaflet |
| Regulatory status in Ireland | Food supplement under FSAI guidelines, not a medicine. 13.5% VAT applies. |
| Irish supply | Probiotic.ie, authorised Irish distributor. Refrigerated storage and tracked dispatch from Dublin. |
Clinical evidence attaches to the exact formulation and dose used in a trial, not to a species name. Two products can both list Lactobacillus acidophilus and contain entirely different strains from different deposits, with different published evidence behind them. This is why deposit codes on a label are more useful than the species list, and why results from one product cannot be assumed to transfer to another.
The clinical research discussed in this article relates to the De Simone Formulation as a studied formulation. It should not be read as a claim that CDS22-formula produces these effects. No clinical trial has been conducted on CDS22-formula under that product name. CDS22-formula is a food supplement, not a medicine, and is not intended to diagnose, treat, cure or prevent any disease. No authorised EU or Irish health claim is made for it on this page. Probiotic.ie sells CDS22-formula and is not a neutral party on this subject.
CDS22-formula, available in Ireland
The original 8-strain De Simone Formulation. 450 billion CFU per sachet. Eight strains identified by NCIMB deposit code. Held refrigerated in Dublin and dispatched on a tracked service.
Probiotics for Bloating Ireland: Common Questions Answered
For some people, yes, but the benefit is strain-specific and dose-dependent. Carabotti et al. (Microorganisms, 2024) report a meta-analysis of 17 randomised controlled trials finding a significant effect of probiotics on bloating scores. Multi-strain formulations show the most consistent clinical signal. Single-strain, low-dose products have limited evidence for bloating specifically. Probiotics are most likely to help when bloating is related to gut microbiome imbalance, IBS, or post-antibiotic disruption. They will not resolve bloating caused by dietary intolerances, constipation, or structural issues.
Look for named strains with published deposit codes such as NCIMB codes, so you can cross-reference the product against specific clinical trials. Prefer multi-strain formulations, since Goodoory et al. (Gastroenterology, 2023) found a signal for combination probiotics that was not present for single-strain Lactobacillus or Saccharomyces products. Check the storage instructions, and commit to at least 4 to 8 weeks, which is the window used in most trials showing a benefit. Probiotics are food supplements, not medicines, and no product is authorised to treat bloating.
Most clinical trials showing a benefit used 4 to 8 weeks of supplementation. Do not judge a probiotic on a 1 to 2 week trial. Some people experience a temporary increase in gas in the first week or two as the gut adjusts, which is common and usually short-lived.
Yes, temporarily. Introducing large numbers of live bacteria to an imbalanced gut can cause a brief increase in gas and bloating. This typically settles within 1 to 2 weeks. If symptoms are severe or persist, consult a GP to rule out small intestinal bacterial overgrowth or other causes.
Products sold as bloating tablets typically contain simeticone or activated charcoal and act on gas physically, for short-term symptomatic comfort. Probiotics are live bacteria taken over weeks with the aim of changing gut microbiota composition. They work through completely different mechanisms and neither is a treatment for any disease.
Yes. CDS22-formula is available in Ireland in sachet and capsule format from Probiotic.ie, the authorised Irish distributor, with tracked nationwide delivery from Dublin. It is the original 8-strain De Simone Formulation, providing 450 billion CFU per sachet, with each strain identified on the Irish label by its NCIMB deposit code. It is a food supplement, not a medicine.
CFU is one factor among several and a higher number is not automatically better. What matters more is whether the specific formulation and dose you are taking matches one that has been studied. Clinical evidence attaches to the formulation and dose used in a trial, not to a species name at an unstudied dose. Check the individual papers for the exact dosing used.
Often it is a contributing factor. A 2025 study in In Vivo (2025;39(6):3320-3328) found that 90.5% of patients with functional abdominal bloating showed a dysbiosis index of 15 or higher, with reduced levels of beneficial bacteria and elevated Proteobacteria. Bloating also has causes unrelated to the microbiome, including food intolerances, constipation, motility disorders and structural conditions, which is why persistent symptoms should be assessed by a GP.
Further Reading on Probiotics and Gut Health in Ireland
Sources and References
- [1] Functional Abdominal Bloating Is Associated With Gut Microbiota Dysbiosis and Altered Intestinal Barrier Function. In Vivo. 2025;39(6):3320-3328 — iv.iiarjournals.org
- [2] Carabotti M, et al. Functional Abdominal Bloating and Gut Microbiota: An Update. Microorganisms. 2024;12(8):1669. PMC11357468 — pmc.ncbi.nlm.nih.gov
- [3] Kim HJ, Camilleri M, McKinzie S, et al. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2003;17(7):895-904. PMID 12656692 — pubmed.ncbi.nlm.nih.gov
- [4] Kim HJ, Vazquez Roque MI, Camilleri M, et al. A randomized controlled trial of a probiotic combination VSL#3 and placebo in irritable bowel syndrome with bloating. Neurogastroenterol Motil. 2005;17(5):687-696. PMID 15836468 — pubmed.ncbi.nlm.nih.gov
- [5] Goodoory VC, et al. Efficacy of Probiotics in Irritable Bowel Syndrome: Systematic Review and Meta-analysis. Gastroenterology. 2023;165(5):1206-1218 — gastrojournal.org
- [6] Andresen V, et al. ESPCG International Guide on Probiotics for Lower Gastrointestinal Symptoms. Aliment Pharmacol Ther. 2018. PMC5900870 — pmc.ncbi.nlm.nih.gov
- [7] Ringel-Kulka T, et al. L. acidophilus NCFM and B. lactis Bi-07 versus placebo for bloating in functional bowel disorder. PMC4372813 — pmc.ncbi.nlm.nih.gov
- [8] FSAI guidance on food supplements — fsai.ie